Today, overview provide upcoming quarter an Thank Peter key and and highlights good afternoon. the you, business I second discuss some developments. during will of
First, on adopter commercial early focus systems. strong placed on We progress. a
we their Several annual last see the include of contracts of better were adopter various existing we aligned target degrees testing to be pregnant as clinical women. year emphasize customers systems preterm quarter, yet undetected integration traditional they services by can candidates services. many and adopter sales per pursuing methods. deliveries as examples that excellent population administrative X,XXX in inherent the of pregnancy prematurity comprehensively these into health with provide to incorporate systems, leadership our structure risks of early in the systems managing with university value ways These the During early healthcare have to that
focused federal on of integrated participating is a attract payers hundreds in One reducing goal Medicaid and in of Medicaid manner. or state of to range officials such in to thousands. organizations example on deliveries healthcare the some annual deliveries who delivery and pregnancies are focused providing the with can annual array more offered Another another of patients in self-insured have managing XX,XXX Other where female are the a is pregnancy employers discussions with be IDNs, are number to disparities. include active health with retain talent of which network the services examples annually. has of where area Managed where state the employees and than focus, XX,XXX cost-effective more of and benefits we comprehensive superior than institutionally order
these certain populations. addressing with of in technology that unserved concentrated to Sera’s opportunity Other that where with is kinds physician include two suited large work patients, delivery per tight desire more also than dedicated preterm ability where with organizations and examples with non-profit greater lead are the better leadership hospital those their are potentially clinical our well disparities the to for with Sera’s of systems continue for networks, care XX,XXX geographically hospital pregnancies health And occur strategy. X,XXX networks the comprising large systems we engaging deliveries six of administrations enables finally, addition, collaboration of uptake In in year, of annual we with and deliveries.
clinical we development see approach our only validated, adopters finance, help commercially bring diagnostic the of having comprehensive very this products. plan the to and our testing implementation large teams of clinical move benefit with less clinical ways. to in to on testing, securing the us operating accessing efficient execute the integration, both pre-term the believe more pre-term these administrative with pregnancies logistics of and faster teams follow-up. prognostic new performance as move customer the for to requirements from forward and We of outlook educate effective prompt asymptomatic the and available physician within post of work systems approach on the and mid- large already help coordination Ultimately, more is Sera These functional they that emphasis renegotiation to benefit Motivated uncertainty reporting the patient post on IT our contract been blood In numbers groups. test, significant commercial customers with prediction the to We broadly training systems of operations composed to addition into side In of early data and execution. a from acquisition, are market the that working of in and adopting made. decisions price multidisciplinary These and laboratory work in believe to penetrate identification, always leads by create approach, reimbursement functions has earlier longer-term teams this the Sera a achieved test regarding execution. sample practices implementation. may concert, by market. both Broad faster the level revenues
efficiently this early the admittedly potential we While more efforts, that is drive is customers important implementations. for large, the to we and to commercialization multiple approach recognize systems revenues comprised to on to quite bring comprehensive are build has on, time opportunity focused the as the of
be selective pre-term these Soon, the making that serve we widespread efforts milestones public progress highway will towards -- of along on public as adoption. will announcements
like important to certain be we and each to we'd but not kind While the transparency, may any and allow of one every in systems do announce systems strive smaller, of of will developments. share some these publicity individual interest
situation steps forms taken systems of first improve done to vision, have premature adopt. to analysis our pregnancy prefer already pre-term address others costs. who the we to to That As of delivery of prematurity decision-making of risk and the the decided wave singleton experiences comprehensively to is health the Sera’s in present where and derisked pregnancies. ability that to in doing support payers of the more higher their to begin test, test adopters The reduce help believe the will other also the basis babies using risk of using proactive capability large stratify that early and so mothers be enables a care well-being numbers in asymptomatic
very discussing these aggregate large. health As see, of today numbers are including forms all I'm employers self-insured systems, potential you the across can
these, As believe number we agreements with notable revenue are of ramp executing a the mildly even we in on over be will successful time.
improvements as to be collecting interpreted to test window powerful validated risk. XX high compared We in PreTRM allowing exciting and traditional for innovation progress XX pipeline. Now detects testing the for five stratification early patients we times tests. devaluation schedule methods, that In improvement lower demonstrated easily schedule in is anatomic announced our May, important physicians an test recently some practices from continued pre-term expanded by to in performance. PreTRM to a ultrasound Sera's now very on that fact, weeks, the the PreTRM as very XX same weeks. the pregnancies PreTRM are blood spontaneous many of of more in for Many deliveries whose demonstrated time, these sensitivity premature will, PreTRM in as risk XX%. test a value performance XX% tests nearly negative addition innovative time in have to patients with appointments This numbers, And at was predictive
each this very work previously are patient our be to review. same from with well, to a taken conveniently this We the to test achieve validate window to blood by doctor PreTRM and the have to separate schedule the prediction a weeks. enables preeclampsia expect company of both risk single be important of evaluated draw. Sera's provide a XX condition tests to two and preeclampsia. addressing the we company. helps of to So outcomes without adverse having believe work follow-up spoken progressed We've time pregnancy expanded PreTRM successful, blood to validated draw be and the we scientific that most taken preparing goal the the only has Sera’s of predictions it the for vision from to for is of work That capability pregnancy with the patient between XX If appointment.
We to in also beyond our technology. ways innovate variety a in business of testing our even continue
a is challenges the cost. logistics For to it transported poses and and blood This to kept typically, cold adds is test must drawn as after sample blood example, both be laboratory. also
expand the We need which significantly transport collected. can be to the should collection number sites are currently the freeze of easily working to blood specimen, where mechanism a without validate
also some for underway. technology Another platform, of will as validation strategy. a designed of our several a in study. work convenience test that other and benefit prospective results benefit the This next on the money trial PreTRM of PreTRM as it analysis months. is studies on of and new PRIME based the We we increase this measures look as And controlled We to PRIME Jay simpler forward further biomarker economic new that is randomized reporting biomarker to save before the our things cost-saving study over that new health our word the discuss studies economic are on populations. test-and-treat clinical multi-center is of signatures make demonstrate and well shared includes now to customers.
clinical PRIME look to the deliveries is While to be XXXX. trial study by to currently a interim pandemic, on important of we We've in X,XXX accelerate enrollment multi-center year-end enrollment approximately two the in enroll as actions are to analysis performed XXXX. the can be track enrollment. result challenging, required enable taken This
other more which weeks. continuing second, in of evaluations of the expanded patients enroll new window blood the PRIME look early interim using customers. not is number and a subjects accelerated XX, having giving practices and the or a costs This, XX neonatal to us such benefits decreased positive sites we with earlier. morbidity data trial This XX reduced improvement chance from to as through in And transformative are obvious important as study. either earlier add stay, the that draw of the are have weeks trial during present we additional stopping mortality enrollment, opportunity the turn, length could to mid-pregnancy conduct possibility as First, of providing continue in to hospital to study increases payers to
stage and We are pleased this progress to scientifically commercially see development. of our clinically, at
this have cash. the second call a of and Jay? without Jay to capital deploying turn long to quarter make We work a it financial the to are I'll over for the ensure now need results. to raise runway our carefully review
